Breaking News

ASLAN Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

ASLAN Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

ASLAN Pharmaceuticals Restricted

MENLO PARK, Calif. and SINGAPORE, Might 18, 2022 (Globe NEWSWIRE) — ASLAN Prescription drugs (NASDAQ: ASLN), a clinical-phase, immunology-centered biopharmaceutical organization building progressive remedies to completely transform the life of sufferers, these days declared that Dr Carl Firth, CEO, will present a corporation update at the H.C. Wainwright Worldwide Expense Meeting. The meeting will be held practically and in-human being from May well 23 to 26, 2022.

The presentation will be accessible from Tuesday, May 24, 2022, at 7:00am ET for 90 times at this website link and in the Investors part of ASLAN’s internet site.

ASLAN management will also be offered for virtual just one-on-a single meetings all over the conference. Remember to contact your agent at H.C. Wainwright to ask for a meeting.

About ASLAN Prescription drugs
ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-phase, immunology-concentrated biopharmaceutical business producing modern therapies to remodel the life of sufferers. ASLAN is currently analyzing eblasakimab, a prospective 1st-in-course antibody targeting the IL-13 receptor, in atopic dermatitis, and farudodstat (also recognised as ASLAN003), a potent oral inhibitor of the enzyme, DHODH, in autoimmune condition. ASLAN has a crew in Menlo Park, California, and in Singapore. For supplemental facts be sure to stop by www.aslanpharma.com or comply with ASLAN on LinkedIn.

Media and IR contacts